MyBody-X angle on Longevity Basis

MyBody-X approaches longevity not as a single gene trait, but as an interplay of genetics, biomarkers, and lifestyle. DNA analysis can indicate predispositions (e.g., for alcohol metabolism, bone health, or triglyceride levels), but effects are typically small and non-deterministic. GWAS studies show that many 'longevity genes' have weak associations and poor transferability to non-European populations. MyBody-X therefore combines DNA data with blood markers (e.g., vitamin B12, lipids) and validated lifestyle factors. Importantly, no genetic test alone can predict your lifespan. Evidence for direct gene-diet recommendations is limited – many DTC claims (e.g., FTO diet type) have been refuted by RCTs. Our approach is evidence-based: we highlight risk areas but recommend individual actions only after confirmation via biomarkers and physician consultation. Longevity is multifactorial – genetics is just one piece of the puzzle.